NYSE:MDT - Medtronic Stock Price, Price Target & More

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic declared a quarterly dividend on Friday, March 9th. Shareholders of record on Friday, March 23rd will be given a dividend of $0.46 per share on Friday, April 13th. This represents a $1.84 annualized dividend and a dividend yield of 2.12%. The ex-dividend date is Thursday, March 22nd. View Medtronic's Dividend History.

Medtronic declared that its Board of Directors has approved a share buyback program on Thursday, October 5th 2017, which permits the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 49% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board believes its shares are undervalued.

Medtronic PLC (NYSE:MDT) announced its earnings results on Thursday, May, 24th. The medical technology company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.39 by $0.03. The medical technology company had revenue of $8.14 billion for the quarter, compared to analyst estimates of $8 billion. Medtronic had a net margin of 10.36% and a return on equity of 12.84%. Medtronic's quarterly revenue was up 2.9% on a year-over-year basis. During the same period last year, the business posted $1.33 earnings per share. View Medtronic's Earnings History.

Medtronic is scheduled to release their next quarterly earnings announcement on Tuesday, August, 28th 2018. View Earnings Estimates for Medtronic.

Medtronic issued an update on its FY19 earnings guidance on Thursday, May, 24th. The company provided earnings per share (EPS) guidance of $5.10-5.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.14.

22 brokers have issued 12 month price targets for Medtronic's shares. Their predictions range from $80.00 to $103.00. On average, they expect Medtronic's share price to reach $92.8158 in the next year. View Analyst Ratings for Medtronic.

Some companies that are related to Medtronic include SONOVA Hldg AG/ADR (SONVY), Varian Medical Systems (VAR), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), AxoGen (AXGN), Natus Medical (BABY), Cutera (CUTR), Viewray (VRAY), Rockwell Medical (RMTI), Vision Sciences (CGNT), BioLife Solutions (BLFS) and Helius Medical Technologies (HSDT).

News headlines about MDT stock have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Medtronic earned a coverage optimism score of 0.05 on Accern's scale. They also assigned media coverage about the medical technology company an impact score of 45.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Medtronic's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.08%), Massachusetts Financial Services Co. MA (4.42%), Franklin Resources Inc. (2.65%), Artisan Partners Limited Partnership (1.66%), Northern Trust Corp (1.19%) and Barrow Hanley Mewhinney & Strauss LLC (1.12%). Company insiders that own Medtronic stock include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Gary Lee Ellis, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, James T Lenehan, Kendall J Powell, Omar Ishrak, Richard H Anderson, Richard Kuntz, Robert C Pozen and Shirley A Jackson. View Institutional Ownership Trends for Medtronic.

MDT stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Asset Management One Co. Ltd., Point72 Asset Management L.P., Amundi Pioneer Asset Management Inc., OppenheimerFunds Inc., Swiss National Bank, Massachusetts Financial Services Co. MA and Barrow Hanley Mewhinney & Strauss LLC. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Hooman Hakami, James T Lenehan, Omar Ishrak and Richard Kuntz. View Insider Buying and Selling for Medtronic.

MDT stock was acquired by a variety of institutional investors in the last quarter, including Rockefeller Capital Management L.P., Westwood Holdings Group Inc., BlackRock Inc., Summit Trail Advisors LLC, Wells Fargo & Company MN, Artisan Partners Limited Partnership, OMERS ADMINISTRATION Corp and Neuberger Berman Group LLC. Company insiders that have bought Medtronic stock in the last two years include James T Lenehan, Richard H Anderson and Robert C Pozen. View Insider Buying and Selling for Medtronic.

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDT stock can currently be purchased for approximately $86.81.

Medtronic has a market capitalization of $116.74 billion and generates $29.95 billion in revenue each year. The medical technology company earns $3.10 billion in net income (profit) each year or $4.77 on an earnings per share basis. Medtronic employs 91,000 workers across the globe.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]